CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-12 | Meluzio Michael Vincent VP, Prin. Accounting Officer | Sale | −1,144 | $28.05 | $32K | 47,817 |
| 2026-10-12 | Lin Shao-Lee Chief Executive Officer | Sale | −10,000 | $27.50 | $275K | 695,995 |
| 2026-10-12 | Lin Shao-Lee Chief Executive Officer | Sale | −1,087 | $28.05 | $30K | 694,908 |
| 2026-10-12 | Ray Sumita Chief Legal Compliance Officer | Sale | −1,844 | $28.05 | $52K | 116,701 |
| 2026-08-13 | Meluzio Michael Vincent VP, Prin. Accounting Officer | Sale | −1,519 | $29.37 | $45K | 53,070 |
| 2026-08-13 | Meluzio Michael Vincent VP, Prin. Accounting Officer | Sale | −4,106 | $30.35 | $125K | 48,964 |
| 2026-08-13 | Meluzio Michael Vincent VP, Prin. Accounting Officer | Sale | −3 | $31.13 | $93 | 48,961 |
| 2026-08-13 | Ray Sumita Chief Legal Compliance Officer | Sale | −2,383 | $29.37 | $70K | 124,991 |
| 2026-08-13 | Ray Sumita Chief Legal Compliance Officer | Sale | −6,442 | $30.35 | $196K | 118,549 |
| 2026-08-13 | Ray Sumita Chief Legal Compliance Officer | Sale | −4 | $31.13 | $125 | 118,545 |
| 2026-08-13 | Lin Shao-Lee Chief Executive Officer | Sale | −5,423 | $27.19 | $147K | 718,830 |
| 2026-08-13 | Lin Shao-Lee Chief Executive Officer | Sale | −2,375 | $28.11 | $67K | 716,455 |
| 2026-08-13 | Lin Shao-Lee Chief Executive Officer | Sale | −10,460 | $29.48 | $308K | 705,995 |
| 2026-08-12 | Lin Shao-Lee Chief Executive Officer | Sale | −34,225 | $26.99 | $924K | 730,028 |
| 2026-08-12 | Lin Shao-Lee Chief Executive Officer | Sale | −5,775 | $27.75 | $160K | 724,253 |
| 2023-03-23 | Kiener Peter A Director | Sale | −9,325 | $3.28 | $31K | 357 |
| 2021-11-16 | Kiener Peter A Director | Sale | −1,361 | $18.02 | $25K | 0 |
| 2021-11-15 | Kiener Peter A Director | Sale | −18,815 | $17.92 | $337K | 0 |
| 2021-11-15 | Suri Anish President and CSO | Sale | −8,000 | $18.05 | $144K | 94,038 |
| 2021-11-11 | Suri Anish President and CSO | Sale | −20,000 | $15.07 | $301K | 94,038 |
Page 1 of 3 · 41 trades